---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-076313"
form_type: "8-K"
ticker: "DRIO"
cik: "0001533998"
company_name: "DarioHealth Corp."
filed_at: "2024-06-28T23:59:59+00:00"
generated_at: "2026-06-01T00:33:48.549025+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# DarioHealth amends Series B and B-1 Preferred Stock, extends conversion period, adds dividends

## Summary
- Mandatory conversion period extended from 15 to 18 months from original issue date.
- Series B and B-1 holders get 10% dividend for fifth full quarter, 25% for sixth quarter from closing.
- No additional securities were issued or sold as a result of the amendment.
- Amendments filed on June 25, 2024, effective upon filing with Delaware Secretary of State.

## SEC filing metadata
- accession: 0001104659-24-076313
- form_type: 8-K
- ticker: DRIO
- cik: 0001533998
- company_name: DarioHealth Corp.
- filed_at: 2024-06-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533998/000110465924076313/0001104659-24-076313-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533998/000110465924076313/tm2418444d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-076313
- JSON: https://secwatch.observer/filing/0001104659-24-076313.json
- Plain text: https://secwatch.observer/filing/0001104659-24-076313.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.